The impact of non- and anthracycline-based chemotherapy on fatigue in breast cancer survivors: results from WF-97415.

Nancy E AvisBeverly J LevineHeidi D KlepinShannon L MihalkoPeter H BrubakerTonya MooreAmy C LaddSusan F DentMary Helen HackneyBonnie KyWilliam O NtimLynne I WagnerKathryn E WeaverW Gregory Hundleynull null

Published in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2024)

Women with breast cancer who receive non- or anthracycline-based chemotherapy experience similar trends in and levels of fatigue within the first year of treatment and greater fatigue than women receiving AIs alone or women without breast cancer.

Keyphrases

polycystic ovary syndrome
sleep quality
breast cancer risk
locally advanced
pregnancy outcomes
cervical cancer screening
squamous cell carcinoma
type diabetes
depressive symptoms
metabolic syndrome
pregnant women
physical activity
young adults
combination therapy